BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35858474)

  • 1. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.
    Obaid EAMS; Wu S; Zhong Y; Yan M; Zhu L; Li B; Wang Y; Wu W; Wang G
    Biomater Sci; 2022 Aug; 10(17):4837-4847. PubMed ID: 35858474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy.
    Sun Q; Bi H; Wang Z; Li C; Wang X; Xu J; Zhu H; Zhao R; He F; Gai S; Yang P
    Biomaterials; 2019 Dec; 223():119473. PubMed ID: 31499255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable Imprinted Polymer Based on ZIF-8/DOX-HA for Synergistically Targeting Prostate Cancer Cells and Controlled Drug Release with Multiple Responses.
    Song Y; Han S; Liu S; Sun R; Zhao L; Yan C
    ACS Appl Mater Interfaces; 2023 May; 15(21):25339-25353. PubMed ID: 37212295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pH-Responsive CaO
    Li X; Xu M; Geng Z; Xu X; Han X; Chen L; Ji P; Liu Y
    ACS Appl Mater Interfaces; 2023 Sep; 15(36):42965-42980. PubMed ID: 37656022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy.
    Mi X; Hu M; Dong M; Yang Z; Zhan X; Chang X; Lu J; Chen X
    Int J Nanomedicine; 2021; 16():8337-8352. PubMed ID: 34992370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-responsive Ag-Phy@ZIF-8 nanoparticles modified by hyaluronate for efficient synergistic bacteria disinfection.
    Tan L; Yuan G; Wang P; Feng S; Tong Y; Wang C
    Int J Biol Macromol; 2022 May; 206():605-613. PubMed ID: 35202636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-drug conjugate modified core-shell MOFs as pH responsive nanoplatform for multimodal therapy of glioblastoma.
    Pandey A; Kulkarni S; Vincent AP; Nannuri SH; George SD; Mutalik S
    Int J Pharm; 2020 Oct; 588():119735. PubMed ID: 32763386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-responsive resveratrol-loaded ZIF-8 nanoparticles modified with tannic acid for promoting colon cancer cell apoptosis.
    Sun X; Li F; Yuan L; Bing Z; Li X; Yang K
    J Biomed Mater Res B Appl Biomater; 2024 Jan; 112(1):e35320. PubMed ID: 37702969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
    Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis.
    Song K; Tang Z; Song Z; Meng S; Yang X; Guo H; Zhu Y; Wang X
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
    Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
    Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid coating on the surface of curcumin-loaded ZIF-8 nanoparticles for improved breast cancer therapy: An in vitro and in vivo study.
    Yu S; Wang S; Xie Z; Yu S; Li L; Xiao H; Song Y
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111759. PubMed ID: 33892283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering silk sericin decorated zeolitic imidazolate framework-8 nanoplatform to enhance chemotherapy.
    Li X; Hou S; Chen J; He CE; Gao YE; Lu Y; Jia D; Ma X; Xue P; Kang Y; Xu Z
    Colloids Surf B Biointerfaces; 2021 Apr; 200():111594. PubMed ID: 33561693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic formulation of anticancer peptide loaded ZIF-8 nanoparticles for the treatment of breast cancer.
    Qiu J; Tomeh MA; Jin Y; Zhang B; Zhao X
    J Colloid Interface Sci; 2023 Jul; 642():810-819. PubMed ID: 37043939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles.
    Pan YB; Wang S; He X; Tang W; Wang J; Shao A; Zhang J
    J Mater Chem B; 2019 Dec; 7(48):7683-7689. PubMed ID: 31778139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release.
    Lv Y; Ding D; Zhuang Y; Feng Y; Shi J; Zhang H; Zhou TL; Chen H; Xie RJ
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1907-1916. PubMed ID: 30566326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells.
    Fan Q; Zuo J; Tian H; Huang C; Nice EC; Shi Z; Kong Q
    J Exp Clin Cancer Res; 2022 May; 41(1):162. PubMed ID: 35501823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.